{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:49:41Z","timestamp":1761630581922},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,5,21]],"date-time":"2011-05-21T00:00:00Z","timestamp":1305936000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s11908-011-0196-6","type":"journal-article","created":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T05:06:06Z","timestamp":1305867966000},"page":"380-386","source":"Crossref","is-referenced-by-count":7,"title":["The Changing Landscape of Progressive Multifocal Leukoencephalopathy"],"prefix":"10.1007","volume":"13","author":[{"given":"Sachin","family":"Kedar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph R.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,21]]},"reference":[{"key":"196_CR1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/brain\/81.1.93","volume":"81","author":"KE Astrom","year":"1958","unstructured":"Astrom KE, Mancall EL, Richardson Jr EP. Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin\u2019s disease. Brain. 1958;81:93\u2013111.","journal-title":"Brain"},{"issue":"7712","key":"196_CR2","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0140-6736(71)91777-6","volume":"1","author":"BL Padgett","year":"1971","unstructured":"Padgett BL, Walker DL, ZuRhein GM, et al. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet. 1971;1(7712):1257\u201360.","journal-title":"Lancet"},{"key":"196_CR3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0168-1702(84)90032-7","volume":"1","author":"K Dorries","year":"1984","unstructured":"Dorries K. Progressive multifocal leucoencephalopathy: analysis of JC virus DNA from brain and kidney tissue. Virus Res. 1984;1:25\u201338.","journal-title":"Virus Res"},{"key":"196_CR4","doi-asserted-by":"crossref","first-page":"9918","DOI":"10.1128\/JVI.72.12.9918-9923.1998","volume":"72","author":"MC Monaco","year":"1998","unstructured":"Monaco MC, Jensen PN, Hou J, et al. Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection. J Virol. 1998;72:9918\u201323.","journal-title":"J Virol"},{"key":"196_CR5","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1086\/504947","volume":"43","author":"JR Berger","year":"2006","unstructured":"Berger JR, Miller CS, Mootoor Y, et al. JC virus detection in bodily fluids: clues to transmission. Clin Infect Dis. 2006;43:e9\u201312.","journal-title":"Clin Infect Dis"},{"key":"196_CR6","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1348-0421.1982.tb00254.x","volume":"26","author":"F Taguchi","year":"1982","unstructured":"Taguchi F, Kajioka J, Miyamura T. Prevalence rate and age of acquisition of antibodies against JC virus and BK virus in human sera. Microbiol Immunol. 1982;26:1057\u201364.","journal-title":"Microbiol Immunol"},{"key":"196_CR7","first-page":"99","volume-title":"Polyomaviruses and human neurological disease","author":"D Walker","year":"1983","unstructured":"Walker D, Padgett B. The epidemiology of human polyomaviruses. In: Sever J, Madden D, editors. Polyomaviruses and human neurological disease. New York: Alan R. Liss; 1983. p. 99\u2013106."},{"key":"196_CR8","first-page":"161","volume-title":"Comprehensive virology","author":"D Walker","year":"1983","unstructured":"Walker D, Padgett B. Progressive multifocal leukoencephalopathy. In: Fraenkel-Conrat H, Wagner R, editors. Comprehensive virology. New York: Plenum; 1983. p. 161\u201393."},{"key":"196_CR9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jmv.10450","volume":"71","author":"WA Knowles","year":"2003","unstructured":"Knowles WA, Pipkin P, Andrews N, et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol. 2003;71:115\u201323.","journal-title":"J Med Virol"},{"key":"196_CR10","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/jmv.21710","volume":"82","author":"A Matos","year":"2010","unstructured":"Matos A, Duque V, Beato S, et al. Characterization of JC human polyomavirus infection in a Portuguese population. J Med Virol. 2010;82:494\u2013504.","journal-title":"J Med Virol"},{"key":"196_CR11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jneuroim.2005.01.001","volume":"162","author":"S Wickham","year":"2005","unstructured":"Wickham S, Lu B, Ash J, Carr DJ. Chemokine receptor deficiency is associated with increased chemokine expression in the peripheral and central nervous systems and increased resistance to herpetic encephalitis. J Neuroimmunol. 2005;162:51\u20139.","journal-title":"J Neuroimmunol"},{"key":"196_CR12","first-page":"161","volume":"18","author":"T Solomon","year":"2004","unstructured":"Solomon T, Winter PM. Neurovirulence and host factors in flavivirus encephalitis\u2014evidence from clinical epidemiology. Arch Virol Suppl. 2004;18:161\u201370.","journal-title":"Arch Virol Suppl"},{"key":"196_CR13","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/ana.1004","volume":"49","author":"F Weber","year":"2001","unstructured":"Weber F, Goldmann C, Kramer M, et al. Cellular and humoral immune response in progressive multifocal leukoencephalopathy. Ann Neurol. 2001;49:636\u201342.","journal-title":"Ann Neurol"},{"key":"196_CR14","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/infdis\/127.4.467","volume":"127","author":"BL Padgett","year":"1973","unstructured":"Padgett BL, Walker DL. Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. J Infect Dis. 1973;127:467\u201370.","journal-title":"J Infect Dis"},{"key":"196_CR15","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/00002030-199208000-00012","volume":"6","author":"JR Berger","year":"1992","unstructured":"Berger JR, Scott G, Albrecht J, et al. Progressive multifocal leukoencephalopathy in HIV-1-infected children. AIDS. 1992;6:837\u201341.","journal-title":"AIDS"},{"key":"196_CR16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ana.22128","volume":"68","author":"L Gorelik","year":"2010","unstructured":"\u2022 Gorelik L, Lerner M, Bixler S, et al. Anti-JC virus antibodies: implications for PML risk stratification. Ann Neurol. 2010;68:295\u2013303. These authors describe the utility of a two-step assay for identifying patients at risk for developing PML based on the presence of antibodies to the JC virus.","journal-title":"Ann Neurol"},{"key":"196_CR17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0733-8619(18)31105-8","volume":"2","author":"BR Brooks","year":"1984","unstructured":"Brooks BR, Walker DL. Progressive multifocal leukoencephalopathy. Neurol Clin. 1984;2:299\u2013313.","journal-title":"Neurol Clin"},{"key":"196_CR18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/13550289809113482","volume":"4","author":"JR Berger","year":"1998","unstructured":"Berger JR, Pall L, Lanska D, Whiteman M. Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol. 1998;4:59\u201368.","journal-title":"J Neurovirol"},{"key":"196_CR19","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1086\/514083","volume":"176","author":"RM Selik","year":"1997","unstructured":"Selik RM, Karon JM, Ward JW. Effect of the human immunodeficiency virus epidemic on mortality from opportunistic infections in the United States in 1993. J Infect Dis. 1997;176:632\u20136.","journal-title":"J Infect Dis"},{"key":"196_CR20","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJM198212023072307","volume":"307","author":"JR Miller","year":"1982","unstructured":"Miller JR, Barrett RE, Britton CB, et al. Progressive multifocal leukoencephalopathy in a male homosexual with T- cell immune deficiency. N Engl J Med. 1982;307:1436\u20138.","journal-title":"N Engl J Med"},{"key":"196_CR21","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/ana.410170407","volume":"17","author":"LB Krupp","year":"1985","unstructured":"Krupp LB, Lipton RB, Swerdlow ML, et al. Progressive multifocal leukoencephalopathy: clinical and radiographic features. Ann Neurol. 1985;17:344\u20139.","journal-title":"Ann Neurol"},{"key":"196_CR22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-107-1-78","volume":"107","author":"JR Berger","year":"1987","unstructured":"Berger JR, Kaszovitz B, Post MJ, Dickinson G. Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases. Ann Intern Med. 1987;107:78\u201387.","journal-title":"Ann Intern Med"},{"key":"196_CR23","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/0046-8177(91)90293-X","volume":"22","author":"K Kure","year":"1991","unstructured":"Kure K, Llena JF, Lyman WD, et al. Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. Hum Pathol. 1991;22:700\u201310.","journal-title":"Hum Pathol"},{"key":"196_CR24","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF00687372","volume":"77","author":"W Lang","year":"1989","unstructured":"Lang W, Miklossy J, Deruaz JP, et al. Neuropathology of the acquired immune deficiency syndrome (AIDS): a report of 135 consecutive autopsy cases from Switzerland. Acta Neuropathol. 1989;77:379\u201390.","journal-title":"Acta Neuropathol"},{"key":"196_CR25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0344-0338(11)80087-7","volume":"189","author":"K Kuchelmeister","year":"1993","unstructured":"Kuchelmeister K, Gullotta F, Bergmann M, et al. Progressive multifocal leukoencephalopathy (PML) in the acquired immunodeficiency syndrome (AIDS). A neuropathological autopsy study of 21 cases. Pathol Res Pract. 1993;189:163\u201373.","journal-title":"Pathol Res Pract"},{"key":"196_CR26","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1212\/WNL.44.10.1892","volume":"44","author":"H Bacellar","year":"1994","unstructured":"Bacellar H, Munoz A, Miller EN, et al. Temporal trends in the incidence of HIV-1-related neurologic diseases: multicenter AIDS Cohort Study, 1985\u20131992. Neurology. 1994;44:1892\u2013900.","journal-title":"Neurology"},{"issue":"Suppl 1","key":"196_CR27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/13550280390195261","volume":"9","author":"JR Berger","year":"2003","unstructured":"Berger JR. Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: explaining the high incidence and disproportionate frequency of the illness relative to other immunosuppressive conditions. J Neurovirol. 2003;9 Suppl 1:38\u201341.","journal-title":"J Neurovirol"},{"key":"196_CR28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/mds.870080120","volume":"8","author":"C Singer","year":"1993","unstructured":"Singer C, Berger JR, Bowen BC, et al. Akinetic-rigid syndrome in a 13-year-old girl with HIV-related progressive multifocal leukoencephalopathy. Mov Disord. 1993;8:113\u20136.","journal-title":"Mov Disord"},{"key":"196_CR29","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s002340050383","volume":"39","author":"MC Morriss","year":"1997","unstructured":"Morriss MC, Rutstein RM, Rudy B, et al. Progressive multifocal leukoencephalopathy in an HIV-infected child. Neuroradiology. 1997;39:142\u20134.","journal-title":"Neuroradiology"},{"issue":"Suppl 1","key":"196_CR30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/13550280390195397","volume":"9","author":"SK Shankar","year":"2003","unstructured":"Shankar SK, Satishchandra P, Mahadevan A, et al. Low prevalence of progressive multifocal leukoencephalopathy in India and Africa: is there a biological explanation. J Neurovirol. 2003;9 Suppl 1:59\u201367.","journal-title":"J Neurovirol"},{"key":"196_CR31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1086\/595299","volume":"199","author":"FN Engsig","year":"2009","unstructured":"Engsig FN, Hansen AB, Omland LH, et al. Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study. J Infect Dis. 2009;199:77\u201383.","journal-title":"J Infect Dis"},{"key":"196_CR32","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000311014","volume":"35","author":"KL Christensen","year":"2010","unstructured":"Christensen KL, Holman RC, Hammett TA, et al. Progressive multifocal leukoencephalopathy deaths in the USA, 1979\u20132005. Neuroepidemiology. 2010;35:178\u201384.","journal-title":"Neuroepidemiology"},{"key":"196_CR33","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1212\/WNL.0b013e3181f73600","volume":"75","author":"KL Amend","year":"2010","unstructured":"Amend KL, Turnbull B, Foskett N, et al. Incidence of progressive multifocal leukoencephalopathy in patients without HIV. Neurology. 2010;75:1326\u201332.","journal-title":"Neurology"},{"key":"196_CR34","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1002\/art.24966","volume":"60","author":"ES Molloy","year":"2009","unstructured":"Molloy ES, Calabrese LH. Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases. Arthritis Rheum. 2009;60:3761\u20135.","journal-title":"Arthritis Rheum"},{"key":"196_CR35","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1474-4422(10)70028-4","volume":"9","author":"DB Clifford","year":"2010","unstructured":"\u2022 Clifford DB, De Luca A, Simpson DM, et al. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol. 2010;9:438\u201346. This is an excellent publication describing clinical and radiologic features of PML as well as potential risk-mitigation strategies for the development of PML in patients treated with natalizumab.","journal-title":"Lancet Neurol"},{"key":"196_CR36","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1474-4422(07)70078-9","volume":"6","author":"L Kappos","year":"2007","unstructured":"Kappos L, Bates D, Hartung H-P, et al. Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring. Lancet Neurol. 2007;6:431\u201341.","journal-title":"Lancet Neurol"},{"key":"196_CR37","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1056\/NEJMe058122","volume":"353","author":"JR Berger","year":"2005","unstructured":"Berger JR, Koralnik IJ. Progressive multifocal leukoencephalopathy and natalizumab\u2013unforeseen consequences. N Engl J Med. 2005;353:414\u20136.","journal-title":"N Engl J Med"},{"key":"196_CR38","doi-asserted-by":"crossref","first-page":"583","DOI":"10.4161\/mabs.1.6.9884","volume":"1","author":"JR Berger","year":"2009","unstructured":"Berger JR, Houff SA, Major EO. Monoclonal antibodies and progressive multifocal leukoencephalopathy. MAbs. 2009;1:583\u20139.","journal-title":"MAbs"},{"key":"196_CR39","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJMp0906248","volume":"361","author":"EO Major","year":"2009","unstructured":"Major EO. Reemergence of PML in natalizumab-treated patients\u2013new cases, same concerns. N Engl J Med. 2009;361:1041\u20133.","journal-title":"N Engl J Med"},{"key":"196_CR40","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1056\/NEJMoa030002","volume":"349","author":"M Lebwohl","year":"2003","unstructured":"Lebwohl M, Tyring SK, Hamilton TK, et al. A novel targeted T-cell modulator, efalizumab, for plaque psoriasis. N Engl J Med. 2003;349:2004\u201313.","journal-title":"N Engl J Med"},{"key":"196_CR41","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1182\/blood-2008-10-186999","volume":"113","author":"KR Carson","year":"2009","unstructured":"Carson KR, Evens AM, Richey EA, et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood. 2009;113:4834\u201340.","journal-title":"Blood"},{"key":"196_CR42","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1056\/NEJMoa050085","volume":"353","author":"F Vincenti","year":"2005","unstructured":"Vincenti F, Larsen C, Durrbach A, et al. Costimulation blockade with belatacept in renal transplantation. N Engl J Med. 2005;353:770\u201381.","journal-title":"N Engl J Med"},{"key":"196_CR43","unstructured":"FDA\u2019s Cardiovascular and Renal Drugs Advisory Committee: Briefing Document for March 2010 Meeting. Belatacept (BMS-224818). BLA 125288. January 25, 2010. Available at http:\/\/www.fda.gov\/downloads\/advisorycommittees\/committeesmeetingmaterials\/drugs\/cardiovascularandrenaldrugsadvisorycommittee\/ucm201859.pdf ."},{"key":"196_CR44","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood-2007-02-074641","volume":"110","author":"A Gallamini","year":"2007","unstructured":"Gallamini A, Zaja F, Patti C, et al. Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial. Blood. 2007;110:2316\u201323.","journal-title":"Blood"},{"key":"196_CR45","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1086\/504811","volume":"43","author":"SI Martin","year":"2006","unstructured":"Martin SI, Marty FM, Fiumara K, et al. Infectious complications associated with alemtuzumab use for lymphoproliferative disorders. Clin Infect Dis. 2006;43:16\u201324.","journal-title":"Clin Infect Dis"},{"key":"196_CR46","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1586\/ern.10.135","volume":"10","author":"EJ Fox","year":"2010","unstructured":"Fox EJ. Alemtuzumab in the treatment of relapsing-remitting multiple sclerosis. Expert Rev Neurother. 2010;10:1789\u201397.","journal-title":"Expert Rev Neurother"},{"key":"196_CR47","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2165\/11537510-000000000-00000","volume":"33","author":"JR Berger","year":"2010","unstructured":"\u2022 Berger JR. Progressive multifocal leukoencephalopathy and newer biological agents. Drug Saf. 2010;33:969\u201383. This review article describes the risks of PML with newer biologic agents, as well as potential risk-mitigation strategies.","journal-title":"Drug Saf"},{"key":"196_CR48","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1097\/TP.0b013e31818b62c8","volume":"86","author":"RT Neff","year":"2008","unstructured":"Neff RT, Hurst FP, Falta EM, et al. Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation. Transplantation. 2008;86:1474\u20138.","journal-title":"Transplantation"},{"key":"196_CR49","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1086\/597126","volume":"199","author":"A Egli","year":"2009","unstructured":"Egli A, Infanti L, Dumoulin A, et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis. 2009;199:837\u201346.","journal-title":"J Infect Dis"},{"key":"196_CR50","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1126\/science.1103492","volume":"306","author":"GF Elphick","year":"2004","unstructured":"Elphick GF, Querbes W, Jordan JA, et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science. 2004;306:1380\u20133.","journal-title":"Science"},{"key":"196_CR51","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1348-0421.2009.00156.x","volume":"53","author":"S Nukuzuma","year":"2009","unstructured":"Nukuzuma S, Nakamichi K, Nukuzuma C, Takegami T. Inhibitory effect of serotonin antagonists on JC virus propagation in a carrier culture of human neuroblastoma cells. Microbiol Immunol. 2009;53:496\u2013501.","journal-title":"Microbiol Immunol"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-011-0196-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11908-011-0196-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-011-0196-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T09:39:59Z","timestamp":1592559599000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11908-011-0196-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,21]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["196"],"URL":"https:\/\/doi.org\/10.1007\/s11908-011-0196-6","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,21]]}}}